[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"plantar-sensation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:plantar-sensation":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100624631","hows-your-balance-100624631",false,"NCT07412145","How's Your Balance?","Inclusion Criteria:\n\n* Adults, ages 20 and older\n* Able to provide verbal consent\n\nExclusion Criteria:\n\n* Individuals, ages 19 and younger\n* Inability to provide verbal consent",true,"ALL","20 Years",{"count":19,"type":20},1000,"ESTIMATED","OBSERVATIONAL","The goals of this observational study are to investigate the following:\n\n* If there is a relationship between prior falls, single leg stance time, and plantar cutaneous sensitivity as measured by monofilaments.\n* Plantar sensitivity across a broad range of ages.\n* Self-reported physical function related to balance and mobility using the PROMIS® PROWalk™ questionnaire and balance confidence using the Activities-specific Balance Confidence Scale-6 (ABC-6).\n\nParticipants will answer questions about themselves and their balance and falls. Their plantar (bottom of their feet) sensation will also be tested using monofilaments. And they will stand on a force plate with their eyes open and closed in dual and single leg stances for up to 30 seconds.",[24,25,26],"Balance Assessment","Falls","Plantar Sensation",[28,25,29],"Balance","Plantar sensation","RECRUITING","2026-06-22",{"date":33,"type":34},"2026-06-25","ACTUAL",{"date":36,"type":34},"2025-08-23",{"date":38,"type":20},"2028-12",{"name":40,"class":41},"RxFunction Inc.","INDUSTRY",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":65,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":42},"100591359","effect-of-sensory-training-on-functional-performance-balance-gait-in-type-2-diabetic-individuals-with-neuropathy-100591359","NCT06979401","Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy","Effects of Foot Sensory Training on Plantar Sensation, Functional Performance, Balance, Gait and Kinesiophobia in Type 2 Diabetic Individuals With Neuropathy","Inclusion Criteria:\n\n* Being 35-65 years old\n* Being diagnosed with type 2 diabetes\n* Having achieved glycemic control\n* Having given less than 8 correct answers in the Semmes-Weinstein Monofilament test performed with a 5.07 monofilament\n* Getting a Neuropathy Disability Score of 3 and above\n* Being willing to participate in the study\n* Being literate\n\nExclusion Criteria:\n\n* Having a neurological or orthopedic comorbidity\n* Having a respiratory disease such as uncontrolled COPD or asthma\n* Having active lower extremity ulceration\n* Using medications known to affect the postural control system such as benzodiazepines\n* Having nephropathy, retinopathy and diabetic arthritis at a level that may affect mobility in addition to neuropathy\n* Using a walking aid\n* Body Mass Index \\>30\n* Having communication problems\n* Not participating in at least 3 consecutive exercise sessions\n* Not participating in more than 30% of each session","35 Years","65 Years",{"count":53,"type":20},40,"INTERVENTIONAL",[56],"NA","Diabetic peripheral neuropathy (DPN) is a common complication of type 1 and type 2 diabetes. DPN is characterized by significant axonal degeneration and segmental demyelination affecting sensory and motor nerves. The effect of foot sole sensation on gait and balance parameters has been reported in various studies in the literature, however, no study has been found examining the effect of foot sensory training on plantar sensation, functional performance, balance, gait and kinesiophobia in type 2 diabetic individuals with neuropathy. In order to contribute to the literature, 40 type 2 diabetic individuals with neuropathy who applied to the Turgut Ozal Medical Center Endocrinology and Metabolic Diseases Polyclinic will be included in this randomized controlled study. After diabetic foot training is given to all participants, an experimental (20) and a control (20) group will be formed with a sequential random method. Foot sensory training will be given to the experimental group, while no intervention will be made to the control group, and sensory training will be given to the participants who wish after the study is completed. All participants will be evaluated for subscapular sense, functional performance, balance, walking and kinesiophobia at the beginning and end of the training. Subscapular sense will be evaluated with light touch, two-point discrimination and vibration tests. Functional performance evaluation will be made with timed up and go test and timed stair ascent-descend test. Kinesiophobia will be analyzed with Tampa Kinesiophobia Scale, Balance; One-Legged Stand Test and Y balance tests and walking will be analyzed with Kinect V2 camera based software. Physical activity levels will be evaluated with International Physical Activity Questionnaire-Short Form. The data taken into the research will be analyzed with SPSS (Statistical Program in Social Sciences) program. The values belonging to the data will be expressed with percentage, mean and standard deviation, and the significance level (p) will be taken as 0.05 for comparison tests.",[59,60,61,62,28,63,64,26],"Diabetes","Type 2 Diabetes","Diabetic Peripheral Neuropathy","Kinesiophobia","Functional Performance","Gait Analysis",[66,26,67,68,69,70,71],"balance","type 2 diabetes","gait","kinesiophobia","functional performance","diabetic peripheral neurophaty","NOT_YET_RECRUITING","2025-05-16",{"date":75,"type":34},"2025-05-19",{"date":77,"type":20},"2025-06-15",{"date":79,"type":20},"2025-12-15",{"name":81,"class":82},"Aylin DEMİR","OTHER"]